Medscape1d
Activated Partial Thromboplastin Time versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
The most prevalent reasons for exclusion included heparin infusion for less than ... exclusion in 13 of 40 patients excluded from the anti-Xa HA group and 9 of 32 patients excluded from the ...
Nature22d
Unfractionated Heparin Therapy and Monitoring
Anti-Xa Assay: A blood test that measures the activity of factor Xa, a key enzyme in the coagulation cascade, to assess the effectiveness of anticoagulants like heparin. Dextran Sulfate (DS): A ...
Nature1mon
Postoperative heparin not routinely needed in low-risk renal transplant recipients
no heparin (group 1); subcutaneous low-molecular-weight heparin (tinzaparin sodium 3,500 anti-Xa IU once daily; group 2); or subcutaneous conventional unfractionated heparin (5,000 IU twice daily ...
Medscape4y
Activated Partial Thromboplastin Time versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
The most common methods for monitoring UFH are the activated partial thromboplastin time (aPTT) and antifactor Xa heparin assay (anti-Xa HA), but both present challenges, and the optimal method to ...